Return On Assets of INTERCEPT PHARMACEUTICALS, INC. from 30 Jun 2013 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2013 to 30 Sep 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Return On Assets for the quarter ending 30 Sep 2023 was -13%, a 132% decline year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Assets for 2022 was 42%.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Assets for 2021 was -17%, a 61% increase from 2020.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Assets for 2020 was -44%, a 8.1% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 -13% -52% -132% 01 Jul 2023 30 Sep 2023
Q2 2023 40% +52% 01 Apr 2023 30 Jun 2023
Q1 2023 39% +52% 01 Jan 2023 31 Mar 2023
Q4 2022 42% +59% 01 Oct 2022 31 Dec 2022
Q3 2022 40% +60% 01 Jul 2022 30 Sep 2022
Q2 2022 -13% +18% +59% 01 Apr 2022 30 Jun 2022
Q1 2022 -13% +25% +66% 01 Jan 2022 31 Mar 2022
Q4 2021 -17% +27% +61% 01 Oct 2021 31 Dec 2021
Q3 2021 -20% +29% +59% 01 Jul 2021 30 Sep 2021
Q2 2021 -31% +17% +35% 01 Apr 2021 30 Jun 2021
Q1 2021 -38% +7% +16% 01 Jan 2021 31 Mar 2021
Q4 2020 -44% +3.9% +8.1% 01 Oct 2020 31 Dec 2020
Q3 2020 -49% +2.9% +5.7% 01 Jul 2020 30 Sep 2020
Q2 2020 -48% +5.8% +11% 01 Apr 2020 30 Jun 2020
Q1 2020 -45% +15% +25% 01 Jan 2020 31 Mar 2020
Q4 2019 -48% +12% +19% 01 Oct 2019 31 Dec 2019
Q3 2019 -51% +14% +21% 01 Jul 2019 30 Sep 2019
Q2 2019 -53% +13% +20% 01 Apr 2019 30 Jun 2019
Q1 2019 -60% +8.2% +12% 01 Jan 2019 31 Mar 2019
Q4 2018 -60% +2% +3.2% 01 Oct 2018 31 Dec 2018
Q3 2018 -65% -8% -14% 01 Jul 2018 30 Sep 2018
Q2 2018 -67% -12% -23% 01 Apr 2018 30 Jun 2018
Q1 2018 -69% -14% -25% 01 Jan 2018 31 Mar 2018
Q4 2017 -62% -0.04% -0.06% 01 Oct 2017 31 Dec 2017
Q3 2017 -57% +1.8% +3% 01 Jul 2017 30 Sep 2017
Q2 2017 -54% +0.75% +1.4% 01 Apr 2017 30 Jun 2017
Q1 2017 -55% -8.7% -19% 01 Jan 2017 31 Mar 2017
Q4 2016 -62% -26% -74% 01 Oct 2016 31 Dec 2016
Q3 2016 -59% -27% -83% 01 Jul 2016 30 Sep 2016
Q2 2016 -55% -18% -50% 01 Apr 2016 30 Jun 2016
Q1 2016 -46% -22% -92% 01 Jan 2016 31 Mar 2016
Q4 2015 -36% +79% +69% 01 Oct 2015 31 Dec 2015
Q3 2015 -32% +85% +73% 01 Jul 2015 30 Sep 2015
Q2 2015 -37% +98% +73% 01 Apr 2015 30 Jun 2015
Q1 2015 -24% +173% +88% 01 Jan 2015 31 Mar 2015
Q4 2014 -114% -67% -144% 01 Oct 2014 31 Dec 2014
Q3 2014 -117% -54% -84% 01 Jul 2014 30 Sep 2014
Q2 2014 -135% -78% -138% 01 Apr 2014 30 Jun 2014
Q1 2014 -197% 01 Jan 2014 31 Mar 2014
Q4 2013 -47% 01 Oct 2013 31 Dec 2013
Q3 2013 -64% 01 Jul 2013 30 Sep 2013
Q2 2013 -57% 01 Apr 2013 30 Jun 2013

INTERCEPT PHARMACEUTICALS, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2022 42% +59% 01 Jan 2022 31 Dec 2022
2021 -17% +27% +61% 01 Jan 2021 31 Dec 2021
2020 -44% +3.9% +8.1% 01 Jan 2020 31 Dec 2020
2019 -48% +12% +19% 01 Jan 2019 31 Dec 2019
2018 -60% +2% +3.2% 01 Jan 2018 31 Dec 2018
2017 -62% -0.04% -0.06% 01 Jan 2017 31 Dec 2017
2016 -62% -26% -74% 01 Jan 2016 31 Dec 2016
2015 -36% +79% +69% 01 Jan 2015 31 Dec 2015
2014 -114% -67% -144% 01 Jan 2014 31 Dec 2014
2013 -47% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.